LASERVISION/VISX EXCIMER LASER FOR PRK AND PTK (MOBILEXCIMER)

FDA Premarket Approval P960019 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for two add'l indications, myopic astigmatic prk (prka) and high myopia with and without astigmatism for the device. The device, as modified, will be marketed under the trade name mobilexcimer(r) for ptk and prk. The mobilexcimer(r) for ptk and prk remains indicated for the indications listed in fda's letter of 4/27/97 (p960019/s001 and the new indications contained in this supplement.

DeviceLASERVISION/VISX EXCIMER LASER FOR PRK AND PTK (MOBILEXCIMER)
Generic NameExcimer Laser System
ApplicantLASER VISION CENTERS, INC.
Date Received1998-04-17
Decision Date1998-05-05
PMAP960019
SupplementS002
Product CodeLZS 
Advisory CommitteeOphthalmic
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address LASER VISION CENTERS, INC. 540 Maryville Centre Dr., #200 st. Louis, MO 63141

Supplemental Filings

Supplement NumberDateSupplement Type
P960019Original Filing
S002 1998-04-17 Real-time Process
S001 1996-11-22 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.